Webinar symbols and meanings

Webinar:

USP 797: Insights and Resources for Small and Rural Hospitals

USP Chapter 797 expert Clyde Buchanan will present acceptable methods to comply with the chapter. His presentation will focus on the chapter as it applies to small and rural hospitals. He will explain how best to employ the immediate-use exemption, proprietary bag and vial systems, segregated compounding areas in place of clean rooms, compounding isolators and more ways to maintain sterile compounding with the least investment in facilities.

Webinar Preview
(be sure to allow pop-up windows)

USP 797: Insights and Resources for Small and Rural Hospitals Frequently Asked Questions

This presentation is about an hour long.

Speaker

E. Clyde Buchanan, M.S., R.Ph. FASHP

Clyde Buchanan is a pharmacy consultant and recognized expert on compounding sterile preparations and pharmacy planning, budgeting and operations. He is retired from Emory Healthcare in Atlanta where he was Senior Director of Pharmaceutical Services. Mr. Buchanan received his B.S. in Pharmacy from the University of North Carolina and M.S. and residency training from The Ohio State University. Prior to Emory, he held pharmacy leadership positions at Duke University Medical Center and St. John's Hospital in Springfield IL. Mr. Buchanan has served the American Society of Health-System Pharmacists (ASHP) as Chairman of SIG on Administrative Practice; Vice Chair of the Council on Legal and Public Affairs; member of the House of Delegates, several committees, and task forces. Mr. Buchanan has edited and authored four books on sterile compounding and numerous manuscripts and book chapters. He has been a frequent speaker for state and national conferences on USP Chapter <797>.

Learning Objectives and Major Content Areas

1. Describe what problems face small and rural hospitals in complying with USP 797
2. List the problems in order of priority, i.e. the order in which to solve the problems
3. Find sources for training materials, supplies and services for sterile compounding
4. Develop an approach to improving sterile compounding facilities
5. Set up a quality assurance and performance improvement program for sterile compounding